ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity today announced that it received ...
Corporation announced that it received an Incomplete Letter from the FDA on December 23 for its Re-Tain New Animal Drug ...
Ultragenyx shares plunge as bone disease drug fails to reduce fracture rate Ultragenyx Pharmaceutical said on Monday that late-stage studies showed its drug for a type of genetic bone disease failed ...
Merck Animal Health announced the U.S. Food and Drug Administration has granted a conditional approval for Exzolt Cattle-CA1 fluralaner topical solution.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback